Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felipe C Geyer

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Nature Medicine|February 7, 2017
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samplesLuciano G Martelotto, Timour Baslan, Jude Kendall, et al.
Histopathology|December 31, 2019
Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomasFresia Pareja, Michael S Toss, Felipe C Geyer, et al.
The American Journal of Surgical Pathology|July 6, 2018
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for TreatmentCaterina Marchiò, Patrizia Dell'Orto, Laura Annaratone, et al.
Journal of the National Cancer Institute|January 17, 2019
The Genomic Landscape of Mucinous Breast CancerFresia Pareja, Ju Youn Lee, David N Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2016
The Genomic Landscape of Male Breast CancersSalvatore Piscuoglio, Charlotte K Y Ng, Melissa P Murray, et al.
Genome Biology|May 22, 2015
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplificationCharlotte K Y Ng, Luciano G Martelotto, Arnaud Gauthier, et al.
Journal of the National Cancer Institute|March 6, 2018
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation CarriersBritta Weigelt, Rui Bi, Rahul Kumar, et al.
Histopathology|December 3, 2017
Invasion in breast lesions: the role of the epithelial-stroma barrierEmad A Rakha, Islam M Miligy, Kylie L Gorringe, et al.
Breast Cancer Research and Treatment|November 8, 2017
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancerMothaffar F Rimawi, Carmine De Angelis, Alejandro Contreras, et al.
The Journal of Pathology|February 3, 2016
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progressionSalvatore Piscuoglio, Charlotte Ky Ng, Melissa Murray, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Nature Medicine|February 7, 2017
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samplesLuciano G Martelotto, Timour Baslan, Jude Kendall, et al.
Histopathology|December 31, 2019
Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomasFresia Pareja, Michael S Toss, Felipe C Geyer, et al.
The American Journal of Surgical Pathology|July 6, 2018
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for TreatmentCaterina Marchiò, Patrizia Dell'Orto, Laura Annaratone, et al.
Journal of the National Cancer Institute|January 17, 2019
The Genomic Landscape of Mucinous Breast CancerFresia Pareja, Ju Youn Lee, David N Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2016
The Genomic Landscape of Male Breast CancersSalvatore Piscuoglio, Charlotte K Y Ng, Melissa P Murray, et al.
Genome Biology|May 22, 2015
Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplificationCharlotte K Y Ng, Luciano G Martelotto, Arnaud Gauthier, et al.
Journal of the National Cancer Institute|March 6, 2018
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation CarriersBritta Weigelt, Rui Bi, Rahul Kumar, et al.
Histopathology|December 3, 2017
Invasion in breast lesions: the role of the epithelial-stroma barrierEmad A Rakha, Islam M Miligy, Kylie L Gorringe, et al.
Breast Cancer Research and Treatment|November 8, 2017
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancerMothaffar F Rimawi, Carmine De Angelis, Alejandro Contreras, et al.
The Journal of Pathology|February 3, 2016
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progressionSalvatore Piscuoglio, Charlotte Ky Ng, Melissa Murray, et al.
Pageof 9